Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis

We analyzed 50 patients who achieved at least a very good partial response in the RV-MM-EMN-441 study. Patients received consolidation with autologous stem-cell transplantation (ASCT) or cyclophosphamide-lenalidomide-dexamethasone (CRD), followed by Lenalidomide-based maintenance. We assessed minima...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Stefania, Gambella, Manuela, Gilestro, Milena, Muccio, Vittorio Emanuele, Gay, Francesca, Drandi, Daniela, Ferrero, Simone, Passera, Roberto, Pautasso, Chiara, Bernardini, Annalisa, Genuardi, Mariella, Patriarca, Francesca, Saraci, Elona, Petrucci, Maria Teresa, Pescosta, Norbert, Liberati, Anna Marina, Caravita, Tommaso, Conticello, Concetta, Rocci, Alberto, Musto, Pellegrino, Boccadoro, Mario, Palumbo, Antonio, Omedè, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351601/
https://www.ncbi.nlm.nih.gov/pubmed/27779105
http://dx.doi.org/10.18632/oncotarget.12641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351601/
https://www.ncbi.nlm.nih.gov/pubmed/27779105
http://dx.doi.org/10.18632/oncotarget.12641

Ejemplares similares